UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-25
DOI
10.1038/s41598-017-06605-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-inducible factor 1–mediated characteristic features of cancer cells for tumor radioresistance
- (2016) Hiroshi Harada JOURNAL OF RADIATION RESEARCH
- LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis
- (2016) Chan Joo Yeom et al. Oncotarget
- The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways
- (2015) Yu-yu Gu et al. TUMOR BIOLOGY
- UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α
- (2015) Yoko Goto et al. Nature Communications
- Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis
- (2014) L Zeng et al. ONCOGENE
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- Regulation of the pentose phosphate pathway in cancer
- (2014) Peng Jiang et al. Protein & Cell
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- Glucose-6-phosphate dehydrogenase, NADPH, and cell survival
- (2012) Robert C. Stanton IUBMB LIFE
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
- (2012) Hiroshi Harada et al. Nature Communications
- Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
- (2011) K J Harrington et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- How Can We Overcome Tumor Hypoxia in Radiation Therapy?
- (2011) Hiroshi HARADA JOURNAL OF RADIATION RESEARCH
- p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
- (2011) Peng Jiang et al. NATURE CELL BIOLOGY
- Hypoxia-Inducible Factor 1 in Tumor Radioresistance
- (2010) Hiroshi Harada et al. Current Signal Transduction Therapy
- HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
- (2009) G. Semenza CURRENT PHARMACEUTICAL DESIGN
- The intravenous anesthetics barbiturates inhibit hypoxia-inducible factor 1 activation
- (2009) Takuhiko Wakamatsu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Reactive Oxygen Species-generating Mitochondrial DNA Mutation Up-regulates Hypoxia-inducible Factor-1α Gene Transcription via Phosphatidylinositol 3-Kinase-Akt/Protein Kinase C/Histone Deacetylase Pathway
- (2009) Nobuko Koshikawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of glutathione synthesis
- (2008) Shelly C. Lu MOLECULAR ASPECTS OF MEDICINE
- Regulation of cancer cell metabolism by hypoxia-inducible factor 1
- (2008) Gregg L. Semenza SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started